Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
KOBO
KOBO

Kobo Biotech Ltd.

BSE: 531541
Sector: Chemicals
4.10-0.0 (-0.24%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
9.77
P/E (TTM)
-
P/B
-
P/S (TTM)
-
EV/EBITDA
-
CAPE (5Y)
-
ROE (TTM)
-
ROCE (TTM)
-
ROA (TTM)
-
Avg 3Y ROE
-
Earnings 3Y CAGR
-
Sales 3Y CAGR
-
Sales 5Y CAGR
-
Debt/Equity
-
Consensus TP
-
Strong Buy %
-
Promoter Holding
44.95
Pledged %
0.00

Share Price

Track Kobo Biotech Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

4.100.0 (-0.24%)
32.26% in past 1 year
1 Week returns: -5.75 %
Low
4.1
High
4.3
1 Month returns: 1.23 %
Low
3.6
High
5.0
1 Year returns: 38.51 %
Low
2.0
High
10.0
3 Year CAGR: 15.67 %
Low
2.0
High
10.0
5 Year CAGR: -6.71 %
Low
1.9
High
11.9
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Kobo Biotech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of nan% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Neutral
Not enough talking points with neutral stance
Stock in GSM list
The stock has been places in Graded Surveillance Measure (GSM) list (GSM - 0).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00608326.

Financial Snapshot

See detailed analysis

Multi-year trends for Kobo Biotech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00.0 CrMar 20200.0 CrMar 20210.0 CrMar 20220.0 CrMar 2024
Profit After Tax FY
-0k-0k-0k-0k0-19.2 CrMar 2021-15.2 CrMar 2022-5.6 CrMar 2023-4.9 CrMar 2024
ROE FY
-200%-150%-100%-50%0%50%17.3%Mar 2013-49.4%Mar 2014-90.7%Mar 2015-163.8%Mar 2016
EBITDA FY
-0k-0k-0k0-2.2 CrMar 2021-10.5 CrMar 2022-1.5 CrMar 2023-0.9 CrMar 2024

Kobo Biotech Ltd. Shareholding Pattern

Quarterly breakdown of Kobo Biotech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Promoter
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
Indian Promoter
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
44.95
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.66
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
54.39
55.05
55.05
55.05
55.05
55.05
55.05
55.05
55.05
55.05
Bodies Corporate
3.33
2.60
2.88
2.87
2.86
2.90
2.84
2.82
2.84
2.85
2.85
2.88
2.88
2.94
2.94
2.25
2.25
2.18
2.18
2.13
2.78
2.78
2.77
2.77
2.77
2.79
2.80
2.79
4.19
Others (incl. Retail)
No. of shareholders
51.06
5,586
51.79
5,616
51.51
5,629
51.52
5,630
51.53
5,637
51.49
5,628
51.55
5,611
51.57
5,547
51.55
5,527
51.54
5,561
51.54
5,780
51.51
5,983
51.51
5,983
51.45
6,122
51.45
6,122
52.14
6,420
52.14
6,382
52.21
6,403
52.21
6,455
52.26
6,694
52.27
6,714
52.27
6,841
52.28
7,467
52.28
7,798
52.28
7,854
52.26
7,871
52.25
7,894
52.26
7,901
50.86
7,656

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Kobo Biotech Ltd. shares as reported to NSE and BSE.

NameDateTypePriceQty.Value
Multiplier Share & Stock Advisors Private Limited03 Aug 2026sell₹ 7.891.37 lac-
Ronak Anilkumar03 Aug 2026buy₹ 7.671.39 lac-
Dipakkumar Babalbhai Patel17 Jul 2026buy₹ 9.531.97 lac-
Multiplier Share & Stock Advisors Private Limited16 Jul 2026buy₹ 9.821.30 lac-
Deepika Jindal14 Jul 2026buy₹ 9.402.00 lac-
Darshana Mehul Shah16 Jun 2026sell₹ 6.581.46 lac-
Sushma Sanjay Punamiya16 Jun 2026sell₹ 6.581.22 lac-
Mehul Pravin Chandra Shah08 Jun 2026sell₹ 5.231.63 lac-

Corporate Actions

History of Kobo Biotech Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Dividend₹ 1/share
    Record date: 24th Sep 2012Ex-date: 21st Sep 2012
    Announced on: 30th May 2012
  2. Dividend₹ 1/share
    Record date: 25th Jul 2011Ex-date: 22nd Jul 2011
    Announced on: 19th May 2011
  3. Dividend₹ 1/share
    Record date: 24th Sep 2010Ex-date: 23rd Sep 2010
    Announced on: 13th Aug 2010
  4. Dividend₹ 1/share
    Record date: 23rd Sep 2002Ex-date: 18th Sep 2002
    Announced on: 30th Jun 2002

Company Profile

Overview of Kobo Biotech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Kobo Biotech Limited is an India-based company. The Companys business segment is manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The Company is in the corporate insolvency resolution process.
Key personnel
Ajit Annu KamathD
Non-Executive Chairman of the Board, Managing Director
Zeenat Sayeed PathanD
Additional Director
Komal TibrewalD
Additional Director
Rajendra KaimalD
Non-Executive Director
Ms. Urja Vijaykumar ShahD
Independent Women Director
Dr. Sunil PitrodaD
Additional Non-Executive Independent Director
Incorporated on
03 Aug 1993
Last Annual
31 Mar 2024
Last Interim
30 Jun 2024
No. of Employees
-
IPO date
08 Jan 1996
Free Float
1,28,64,039
Phone no.
+912242871210
Address
Survey No. 18, Yawapur Village, Sadasivpet (M), Medak, MEDAK, 502291, India

Frequently Asked Questions

What is the current share price of Kobo Biotech Ltd.?
The current share price of Kobo Biotech Ltd. is ₹ 4.10 as of 23 Oct 2026.
What is the market capitalisation of Kobo Biotech Ltd.?
The market capitalisation of Kobo Biotech Ltd. stands at ₹ 9.77 Cr.
What is the PE ratio of Kobo Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Kobo Biotech Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Kobo Biotech Ltd.?
Kobo Biotech Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of Kobo Biotech Ltd.?
The 52-week high of Kobo Biotech Ltd. is - and the 52-week low is -.
What is the dividend yield of Kobo Biotech Ltd.?
The dividend yield of Kobo Biotech Ltd. is - based on the current market price.
What is the FII and DII holding in Kobo Biotech Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 50.86% of Kobo Biotech Ltd. shares.
What sector does Kobo Biotech Ltd. belong to?
Kobo Biotech Ltd. operates in the Chemicals sector.
What is the beta of Kobo Biotech Ltd.?
The beta of Kobo Biotech Ltd. is 0.59, indicating its price volatility relative to the broader market.
What is the RSI of Kobo Biotech Ltd.?
The 14-day Relative Strength Index (RSI) of Kobo Biotech Ltd. is 40.82, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.